Marathon Capital Management Recursion Pharmaceuticals, Inc. Transaction History
Marathon Capital Management
- $380 Million
- Q2 2024
A detailed history of Marathon Capital Management transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Marathon Capital Management holds 175,220 shares of RXRX stock, worth $1.26 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
175,220
Previous 172,545
1.55%
Holding current value
$1.26 Million
Previous $1.72 Million
23.6%
% of portfolio
0.35%
Previous 0.42%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
285Shares Held
236MCall Options Held
972KPut Options Held
2.4M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl28.1MShares$202 Million1.92% of portfolio
-
Baillie Gifford & CO26.6MShares$191 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$124 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$110 Million1.74% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.29B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...